Thomas G Wiggans insider trades
Open-market stock purchases and sales by Thomas G Wiggans, Director at Pacira BioSciences, Inc, from SEC Form 4 filings since Dec 31, 2009.
Track record: 0% of 6 scored buys are up 5% or more since purchase, averaging -31%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 10, 2026 | PCRX Pacira BioSciences, Inc | Bought (not open market) | — |
Companies traded
- PCRX Pacira BioSciences, Inc: other filings, last Jun 10, 2026
- JSPR Jasper Therapeutics, Inc: 6 buys, last Sep 22, 2025
- ANNX Annexon, Inc: other filings, last Jun 5, 2025
- CBAY CymaBay Therapeutics, Inc: other filings, last Mar 22, 2024
- PRDS Pardes Biosciences, Inc: 3 buys, last Aug 31, 2023
- FMTX Forma Therapeutics Holdings, Inc: other filings, last Oct 14, 2022
- DERM Dermira, Inc: 5 buys, 41 sales, last Feb 20, 2020
- ONXX Onyx Pharmaceuticals Inc: 8 sales, last Oct 1, 2013
- SOMX Somaxon Pharmaceuticals, Inc: 1 sale, last Jul 2, 2012
- SGMO Sangamo Biosciences Inc: other filings, last Jun 1, 2011